EQS-News

STRABAG expands service portfolio in technical facility management with acquisition of parts of VAMED

EQS-News: STRABAG SE / Key word(s): Acquisition STRABAG expands service portfolio in technical facility management with acquisition of parts of VAMED 07.05.2024 / 22:40 CET/CEST The issuer is solely responsible for the content of this announcement.

---

STRABAG expands service portfolio in technical facility management with acquisition of parts of VAMED

• Acquisition of technical operations management and construction projects divisions of Vienna General Hospital (AKH Wien), Austrian project development business and spa holdings
• Purchase agreement signed by joint STRABAG SE and PORR AG holding company, total purchase price around € 90 million
• Finalisation of transaction on part of STRABAG SE subject to approval by Supervisory Board

STRABAG has signed a purchase agreement together with PORR for parts of the VAMED Group, specifically for the technical operations management and construction projects divisions of Vienna General Hospital (AKH Wien) as well as VAMED’s Austrian project development business and its Austrian spa holdings, for a total purchase price of € 90 million. The acquisition expands STRABAG’s service portfolio in technical facility management to include the highly demanding medical sector while enhancing its expertise in project development in the healthcare sector. The agreement remains subject to approval by the Supervisory Board of STRABAG SE.

The acquisition comprises the following parts of the VAMED Group:

• technical operations management and construction projects divisions of Vienna General Hospital (as part of VAMED subsidiaries VKMB and VKP)
• VAMED’s Austrian project development business (as part of VSG and its subsidiaries) 
• Austrian spa holdings

The seller of these holdings is VAMED AG, which is majority-owned by Fresenius SE & Co. KGaA of Germany. The package does not include the project development business outside of Austria, the hospital services business or VAMED’s post-acute business, in particular the rehabilitation business, which was recently sold to PAI Partners.